StockData
20/20 Biolabs, Inc. logo

20/20 Biolabs, Inc. (AIDX) stock

AIDXNasdaqServices-Testing LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/3069% below fair value
$0.18−0.02 (-9.45%)

Close on Nov 16, 2026Market cap $2.36MP/E –Yield –

20/20 Biolabs profit margin

Profit margin (net margin) is net income as a percentage of revenue.

For fiscal 2025 it was -182.8%, against -316.8% the year before.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-182.8%+134.0
FY2024Dec 31, 2024-316.8%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-206.2%–
Q1 FY2026Mar 31, 2026-615.4%–
Q2 FY2025Jun 30, 2025-157.2%–
Q1 FY2025Mar 31, 2025-138.1%–

More 20/20 Biolabs figures

See a number that looks wrong?